TSPO and neoplasm: Another TSPO radioligand, [18F]PBR316, showed tumor uptake of 1.67 ± 0.43% ID/g in mouse model at 1 h after injection with modest binding sensitivity to human single nucleotide polymorphism rs6971.97 Other promising candidates with the capacity to detect prostate adenocarcinoma include [18F]-fluorothymidine ([18F]-FLT), [18F]-NaF, [18F]-F-choline, and [18F]-BAY 864367.99